U.K. Begins Major Research Effort Into Trans Youth Health

A large new study will follow the health and well-being of thousands of transgender and gender nonconforming young people in the U.K., researchers at King’s College London announced Thursday.

The $14 million study will track up to 3,000 children and teens who have received care from the National Health Service (NHS) for gender-relate...

Trump Moves to Bar Abortions at Veterans Affairs Hospitals

The Trump administration aims to bar U.S. veterans from receiving abortions at Department of Veterans Affairs (VA) hospitals in cases of incest, rape or when the pregnancy puts their life at risk.

The move would revoke abortion access for vets and eligible family members expanded in 2022 under the Biden administration. The expansion includ...

Organized Scientific Fraud Is Growing at Alarming Rate

The rise of “fake” science poses a serious threat to the integrity of academic research, a new study warns.

A widespread underground network of fraudsters is pumping out fake scientific results at an ever-increasing pace, researchers reported in the Proceedings of the National Academy of Sciences. 

In fact, ...

Good Weight-Loss Diets Avoid Processed Foods, Study Finds

Want to drop some pounds? Drop the ultra-processed foods, a new study says.

People lost twice as much weight on a diet with minimally processed foods compared to one with ultra-processed products, even though both diets were nutritionally matched, researchers reported Aug. 4 in the journal Nature Medicine.

“The global ...

Veterans' Study Points to Better Treatment for Binge Eating Disorder

There’s a better way of treating binge eating disorder, a new study argues.

The method, called “regulation of cues,” reduced patients’ odds of binge eating by 20% compared to those who got standard cognitive-behavioral therapy (CBT), researchers reported Aug. 4 in JAMA Network Open.

“The study s...

New Drug May Fight a Deadly Bone Marrow Disorder

A recently approved leukemia pill also might help some patients diagnosed with a deadly bone marrow disorder, a new pilot study says.

About 3 in 5 patients with myelodysplastic syndrome (MDS) responded to treatment with olutasidenib (Rezlidhia), which the U.S. Food and Drug Administration (FDA) approved in 2022 for patients with acute myel...